Insider · CIK 0001238403
Daniel K Spiegelman
director
Files at VTVT (vTv Therapeutics Inc.), SPRB (SPRUCE BIOSCIENCES, INC.), MAZE (Maze Therapeutics, Inc.), KYTX (Kyverna Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +458 | - | - | 458 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -458 | - | - | 0 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (right to buy)derivative | +88 | - | - | 88 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (right to buy)derivative | -88 | - | - | 0 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +400 | - | - | 400 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -400 | - | - | 0 | Dec 15, 2025 |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,000 | $0.00 | $0 | 18,000 | Sep 24, 2025 |
| Jul 22, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jul 24, 2025 |
| Jun 10, 2025 | VTVT vTv Therapeutics Inc. | AGrant or award Director stock option (right to buy)derivative | +4,000 | $16.59 | $66k | 10,000 | Jun 12, 2025 |
| May 29, 2025 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Common Stock | +16,634 | $0.00 | $0 | 16,634 | Jun 2, 2025 |
| May 29, 2025 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +65,351 | $0.00 | $0 | 65,351 | Jun 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.